Second Sight Medical Products Stock News

LOS ANGELES & EMERYVILLE, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”) and Nano Precision Medical, Inc. (“NPM”), today announced that they have entered into a definitive agreement under which privately held NPM will merge with a wholly owned subsidiary of Second Sight in an all-stock transaction. NPM will be the surviving company and owned by Second Sight. The resulting company will focus on development of innovative drug and devi

CONMED (NYSE:CNMD) and Second Sight Medical Products (NASDAQ:EYES) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of recent ratings for CONMED and Second Sight Medical []

State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. in the 2nd quarter, according to the company in its most recent Form 13F filing with

State Street Corp purchased a new stake in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 92,394 shares of the medical device companys stock, valued at approximately $456,000. State Street Corp owned 0.24% [] The post State Street Corp Buys New Shares in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .

Northern Trust Corp increased its holdings in shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) by 33.7% in the second quarter, according to its most recent filing with the SEC. The fund owned 34,658 shares of the medical device companys stock after acquiring an additional 8,735 shares during the period. Northern Trust Corps holdings in [] The post Northern Trust Corp Increases Stock Holdings in Second Sight Medical Products, Inc. (NASDAQ:EYES) appeared first on ETF Daily News .

Geode Capital Management LLC grew its position in Second Sight Medical Products, Inc. (NASDAQ:EYES) by 36.5% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 146,527 shares of the medical device companys stock after acquiring an additional 39,151 shares during the quarter. Geode Capital Management []

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer of implantable visual prosthetics that are intended to c

Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today?

EYES stock is set for another day of double-digit gains after the European patent agency approved the company's application. The post EYES Stock: The Artificial Vision News That Has Investors Looking

The stock price of Second Sight Medical Products Inc (NASDAQ: EYES) increased by over 15% pre-market. This is why it happened.

Biotech penny stocks continue to climb, which companies are on your watchlist? The post Top Biotech Penny Stocks to Buy This Week?

Current & former penny stocks to watch if you like biotech right now. The post Best Penny Stocks For Your July 2021 List?

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to c

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to c

LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to cr